Cardiogenesis Reports Second Quarter 2010 Results
Healthcare Market Reports :- Cardiogenesis Corporation, a leading developer of surgical products used to treat cardiac patients suffering from severe angina, today reported financial...
Life Sciences Investing Rebounds in Q2 2010, Rising 52% from the Prior Quarter, According...
Healthcare Market Reports :- Venture capital (VC) funding in the Life Sciences sector, which includes the biotechnology and medical device industries, captured the highest...
Cardinal Health Declares Regular Quarterly Dividend
Healthcare Market Reports :- Cardinal Health today announced that its board of directors has approved a regular quarterly dividend of $0.195 per share, payable...
Solta Medical Reports Second Quarter 2010 Results
Healthcare Market Reports :- Solta Medical, Inc., a global leader in the medical aesthetics market, today announced results for the second quarter ended June...
BD reports $1.878 billion revenue for the third fiscal quarter ended June 30, 2010
BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $1.878 billion for the third fiscal quarter ended...
Hill-Rom Reports 80 Percent Growth in Adjusted Earnings Per Share for Third Quarter
Hill-Rom Holdings, Inc. (NYSE: HRC), announced strong financial results for its fiscal third quarter ended June 30, 2010, and updated its outlook for the...
Encision Reports First Quarter Results
Encision Inc. (OTC Bulletin Board: ECIA), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive...
BD Board Declares Dividend
The Board of Directors of BD (Becton, Dickinson and Company) has declared a quarterly dividend of 37 cents per common share, payable on September...
BioMed Realty Trust Reports Second Quarter 2010 Financial Results
BioMed Realty Trust, Inc., a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results...
Endologix Q2 total revenue increases 19%
Endologix, Inc. , developer of minimally invasive treatments for aortic disorders, announced financial results for the three and six months ended June 30,...
